Defects are normally either standalone items or are downstream references from test runs where a test run has been executed and a defect has occurred during that execution. The traceability browser reflects these in reverse, as the defect appears upstream from the test run which is logically incorrect.
We believe this error should be corrected; how are other life science companies addressing this?
Hi @Jeff_Senley,
Thank you for your question!
It appears that your post has not yet received any response. I am replying to raise awareness. Hopefully, another community member will be able to help.
Also, feel free to add any additional information you think might be relevant. It sometimes helps to have screenshots to better understand what you are trying to do.
Best regards,
You are referring to this, Jeff?
Before I try to answer in more detail, can you please tell me how this affects your business processes, I mean, what is impossible for you because it points in the "wrong" direction?